DOI QR코드

DOI QR Code

Case of seropositive allergic bronchopulmonary aspergillosis in a 10-year-old girl without previously documented asthma

  • Shin, Jeong Eun (Department of Pediatrics, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine) ;
  • Shim, Jae Won (Department of Pediatrics, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine) ;
  • Kim, Deok Soo (Department of Pediatrics, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine) ;
  • Jung, Hae Lim (Department of Pediatrics, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine) ;
  • Park, Moon Soo (Department of Pediatrics, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine) ;
  • Shim, Jung Yeon (Department of Pediatrics, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine)
  • 투고 : 2013.07.12
  • 심사 : 2014.11.04
  • 발행 : 2015.05.10

초록

Allergic bronchopulmonary aspergillosis (ABPA) is a hypersensitivity lung disease due to bronchial colonization of Aspergillus fumigatus that occurs in susceptible patients with asthma or cystic fibrosis. A 10-year-old girl was referred to the Department of Pediatric Pulmonology for persistent consolidations on chest radiography. Pulmonary consolidations were observed in the right upper and left lower lobes and were not resolved with a 4-week prescription of broad-spectrum antibiotics. The patient had a history of atopic dermatitis and allergic rhinitis but no history of asthma. She had no fever but produced thick and greenish sputum. Her breathing sounds were clear. On laboratory testing, her total blood eosinophil count was $1,412/mm^3$ and total serum IgE level was 2,200 kU/L. Aspergillus was isolated in the sputum culture. The A. fumigatus-specific IgE level was 15.4 kU/L, and the Aspergillus antibody test was also positive. A chest computed tomography scan demonstrated bronchial wall thickening and consolidation without bronchiectasis. An antifungal agent was added but resulted in no improvement of pulmonary consolidations after 3 weeks. Pulmonary function test was normal. Methacholine provocation test was performed, revealing bronchial hyperreactivity ($PC_{20}=5.31mg/mL$). Although the patient had no history of asthma or bronchiectasis, ABPA-seropositivity was suspected. Oral prednisolone (1 mg/kg/day) combined with antifungal therapy was started. Pulmonary consolidations began decreasing after 1 week of treatment and completely resolved after 1 month. This is the first observed and treated case of seropositive ABPA in Korean children without previously documented asthma.

키워드

참고문헌

  1. Knutsen AP, Slavin RG. Allergic bronchopulmonary aspergillosis in asthma and cystic fibrosis. Clin Dev Immunol 2011;2011:843763.
  2. Bains SN, Judson MA. Allergic bronchopulmonary aspergillosis. Clin Chest Med 2012;33:265-81. https://doi.org/10.1016/j.ccm.2012.02.003
  3. Ha KA, Kim CK, Chung CY, Kim JS. A case of allergic bronchopulmonary aspergillosis during childhood. J Korean Pediatr Soc 1999;42:284-8.
  4. Greenberger PA, Patterson R. Allergic bronchopulmonary aspergillosis and the evaluation of the patient with asthma. J Allergy Clin Immunol 1988;81:646-50. https://doi.org/10.1016/0091-6749(88)91034-2
  5. D'Urzo AD, McIvor AR. Case report: allergic bronchopulmonary aspergillosis in asthma. Can Fam Physician 2000;46:882-4.
  6. Wang JL, Patterson R, Rosenberg M, Roberts M, Cooper BJ. Serum IgE and IgG antibody activity against Aspergillus fumigatus as a diagnostic aid in allergic bronchopulmonary aspergillosis. Am Rev Respir Dis 1978;117:917-27.
  7. Greenberger PA. Allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 2002;110:685-92. https://doi.org/10.1067/mai.2002.130179
  8. Agarwal R, Aggarwal AN, Gupta D, Bal A, Das A. Case report: a rare cause of miliary nodules: allergic bronchopulmonary aspergillosis. Br J Radiol 2009;82:e151-4. https://doi.org/10.1259/bjr/20940804
  9. Agarwal R. Allergic bronchopulmonary aspergillosis: lessons for the busy radiologist. World J Radiol 2011;3:178-81. https://doi.org/10.4329/wjr.v3.i7.178
  10. Santos A, Loureiro G, Faria E, Chieira C. Itraconazole, an effective adjunctive treatment for allergic bronchopulmonary aspergillosis. J Investig Allergol Clin Immunol 2009;19:404-8.
  11. Agarwal R, Khan A, Gupta D, Aggarwal AN, Saxena AK, Chakrabarti A. An alternate method of classifying allergic bronchopulmonary aspergillosis based on high-attenuation mucus. PLoS One 2010;5:e15346. https://doi.org/10.1371/journal.pone.0015346
  12. Agarwal R, Khan A, Aggarwal AN, Saikia B, Gupta D, Chakrabarti A. Role of inhaled corticosteroids in the management of serological allergic bronchopulmonary aspergillosis (ABPA). Intern Med 2011;50:855-60. https://doi.org/10.2169/internalmedicine.50.4665
  13. Patterson R, Greenberger PA, Radin RC, Roberts M. Allergic bronchopulmonary aspergillosis: staging as an aid to management. Ann Intern Med 1982;96:286-91. https://doi.org/10.7326/0003-4819-96-3-286
  14. Agarwal R. Allergic bronchopulmonary aspergillosis. Chest 2009;135:805-26. https://doi.org/10.1378/chest.08-2586
  15. Erwin GE, Fitzgerald JE. Case report: allergic bronchopulmonary aspergillosis and allergic fungal sinusitis successfully treated with voriconazole. J Asthma 2007;44:891-5. https://doi.org/10.1080/02770900701750197